# Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases

> **NCT03698162** · NA · TERMINATED · sponsor: **University of Southern California** · enrollment: 15 (actual)

## Conditions studied

- Brain Metastases
- Glioma of Brain
- Brain Tumor
- Metastatic Melanoma

## Interventions

- **OTHER:** Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- **OTHER:** Bevacizumab Injection

## Key facts

- **NCT ID:** NCT03698162
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-13
- **Primary completion:** 2023-11-22
- **Final completion:** 2025-03-01
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2025-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03698162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03698162, "Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03698162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*